AQST R&D Expense Growth
Aquestive Therapeutics Inc · R&D Expense Growth
AQST R&D Expense Growth
Latest reported-15.23%period ending
AQST FY R&D Growth (YoY) (0.00% → -15.23%)
Latest values, visible window
High-resolution chart · PNG
AQST r&d expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| -15.2268% | |
| 54.7619% | |
| -25.0386% | |
| 2.5459% | |
| -14.2764% | |
| -3.344% | |
| -10.9813% | |
| 4.4233% | |
| 43.2557% | |
| 0% |